Golden Gravity: Why 2025 May Be The Year Portfolios Come Back To Earth So far, 2025 feels like the year investors remember that real assets are not just relics. They are relevance.
Cava Beats Q1 Expectations, Analyst Names It A 'Top Pick' Amid Expansion Push Cava tops Q1 estimates and earns "Top Pick" status as analyst eyes long-term growth through brand momentum and expansion plans.
Dick's Foot Locker Move Draws Skepticism As Analysts Question Game Plan Telsey Advisory analyst Joseph Feldman trimmed the price forecast for Dick's Sporting Goods from $250 to $220 while keeping an Outperform rating.
Acadia Pharmaceuticals (ACAD) Stock Explodes 26% After Patent Court Victory ACADIA Pharmaceuticals stock jumped 26.4% Friday afternoon. Shares gained following a favorable court ruling.
Bit Digital (BTBT) Shares Surge Despite Mining Revenue Decline Shares of Bit Digital Inc (
NASDAQ:BTBT ) jumped 14.6% to $2.36 on Friday afternoon after the company reported its first-quarter results, showcasing momentum in it
Rocket Pharma's Gene Therapy Shows Promise in ACM Patients, Says Analyst Chardan's Geulah Livshits raises target price for RCKT to $46 and maintains Buy rating after promising data on gene therapy for heart disease.
Birkenstock Keeps Its Footing, Ups Guidance Despite Global Uncertainty Birkenstock now expects FY25 revenue growth to be at the upper end of its prior guidance of 15% to 17% in constant currency.
CoreWeave Surges As Microsoft, OpenAI Deals Fuel Revenue Spike, Wall Street Boost Wall Street analysts raise PT on CRWV. JP Morgan maintains Overweight rating & raises PT from $43 to $66. Needham maintains Buy & raises PT from $55 to $78.
Carvana (CVNA) Stock Is Rising This Week: What's Going On? Carvana shares have jumped sharply after reporting Q1 earnings exceeding Wall Street expectations. Strong sales growth, profitability and raised guidance fueled the significant analyst price target increases.
